FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
31/10/2025
Voltar para busca
Dado oficial do USPTO
MATRICELF
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
MATRICELF
ST13
US500000079391456Classe
5, 42, 44
Pedido
79391456
Registro
7741564
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
36
Atualização mais recente
01/11/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 42, 44
Data de depósito
27/11/2023
Data de registro
01/04/2025
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
01/04/2025
Última transação
01/11/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
22
Localização do titular
IL
Examinador
BROWN,TINA
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
Matricelf Ltd.
Representantes
Mark I. Koffsky Koffsky Schwalb LLC
Classificação técnica
Classes Nice
Classe 5Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Biological implantsimplants comprising living tissue; biological tissue for implantationbiological tissue graftsimplants comprising living tissue; biological tissue cultures for medical purposes; engineered biological tissues for medical purposesengineered biological tissue cultures for medical purposes; engineered human biological tissues for use in regenerative medicineengineered biological tissue cultures for medical purposes for use in regenerative medicine; engineered biological tissues for the treatment of spinal cord injuriesengineered biological tissue cultures for medical purposes for the treatment of spinal cord injuries; biological implants for spinal cord injuriesimplants comprising living tissue; bio-printed personalized medical implants comprised of living tissue; a personalized bio-printed medical tissue implant adapted to fill a surgically defined cavitypersonalized bio-printed implants comprising living tissue; Transplantsimplants comprising living tissue; surgical implants comprising engineered living tissue; surgical implants comprising living tissue grown from stem cells; engineered human hydrogel and differentiated stem cells in the nature of biological tissues in the nature of biological tissue cultures for medical purposes; engineered human hydrogel for medical purposes; stem cells for medical purposes; biomaterials in the nature of biological tissue cells for printing engineered tissues for medical purposes
Classe 42
Scientific services relating to processing human tissues and cellsstem cell production in the nature of development of stem cells and tissue engineering services for processing human tissues and cells; medical and scientific research and development of human tissues and stem cells; medical and scientific research and development in the field of personalized medicine 3D bioprinting; stem cell research services; scientific and technological services in the field of regenerative medicinemedical researchscientific research and development; medical and scientific research and development in the field of regenerative medicine; medical and scientific research and development in the field of spinal cord injuries; pharmaceutical and biological research and development services in the field of tissue regeneration and engineering
Classe 44
Regenerative medicine services; medical servicestissue regeneration services; medical servicestissue regeneration services using tissue engineering technology; medical servicescellular therapy services; medical servicesregenerating and restoration of spinal cord tissue by means of implanting engineered tissues in the spinal cord; biomedical servicestreating human tissues for medical purposes; medical services relating to the removaltreatment and processing of human tissues; medical services relating to the removaltreatment and processing of human tissues for implantation
Publicações
Histórico de despachos e eventos da marca no USPTO.
36 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
14/10/2025
FIMP
FINAL DISPOSITION PROCESSED
14/10/2025
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
29/08/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
13/08/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
13/08/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
01/07/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/04/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
01/04/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/02/2025
PUBO
PUBLISHED FOR OPPOSITION
11/02/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/02/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
22/01/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
21/01/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
21/01/2025
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
21/01/2025
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
07/01/2025
GNFR
FINAL REFUSAL E-MAILED
07/01/2025
CNFR
FINAL REFUSAL WRITTEN
07/01/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
26/12/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
25/12/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
25/12/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
25/12/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
25/12/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
25/12/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
25/12/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
25/12/2024
RFNT
REFUSAL PROCESSED BY IB
11/08/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
25/07/2024
RFRR
REFUSAL PROCESSED BY MPU
25/07/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
30/06/2024
CNRT
NON-FINAL ACTION WRITTEN
29/06/2024
DOCK
ASSIGNED TO EXAMINER
26/06/2024
MAFR
APPLICATION FILING RECEIPT MAILED
24/04/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
20/03/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
14/03/2024
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace MATRICELF ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.